SCM
Sio Capital Management Portfolio holdings
AUM
$249M
This Quarter Return
+2.51%
1 Year Return
+117.71%
3 Year Return
+238.99%
5 Year Return
+411.91%
10 Year Return
+912.87%
AUM
$326M
AUM Growth
+$326M
(-0.62%)
Cap. Flow
+$5.37M
Cap. Flow
% of AUM
1.65%
Top 10 Holdings %
Top 10 Hldgs %
44.11%
Holding
92
New
17
Increased
21
Reduced
15
Closed
17
Top Buys
| 1 |
LJPC
La Jolla Pharmaceutical Company
LJPC
|
$12.1M |
| 2 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$11.7M |
| 3 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$10.7M |
| 4 |
Novartis
NVS
|
$8.3M |
| 5 |
Elevance Health
ELV
|
$8.28M |
Top Sells
| 1 |
Biogen
BIIB
|
$18.6M |
| 2 |
Gilead Sciences
GILD
|
$16M |
| 3 |
CVS Health
CVS
|
$13.8M |
| 4 |
Ascendis Pharma
ASND
|
$10.6M |
| 5 |
Novo Nordisk
NVO
|
$8.47M |
Sector Composition
| 1 | Healthcare | 87.7% |
| 2 | Technology | 1.63% |
| 3 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GWPH
1
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $21.4M | 5.16% |
124,164
+61,978
| +100% | +$10.7M |
|
2
HCA Healthcare
HCA
$94.5B
| $21.2M | 5.12% |
157,184
+49,756
| +46% | +$6.73M |
|
|
WCG
3
DELISTED
Wellcare Health Plans, Inc.
WCG
| $17.8M | 4.3% |
62,495
+41,036
| +191% | +$11.7M |
|
4
GSK
GSK
$79.9B
| $15.2M | 3.66% |
379,500
+117,500
| +45% | +$4.7M |
|
|
MRTX
5
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $13.9M | 3.36% |
135,300
+78,500
| +138% | +$8.09M |
|
6
Medpace
MEDP
$13.4B
| $12.2M | 2.93% |
185,815
+3,949
| +2% | +$258K |
|
|
LJPC
7
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $12.1M | 2.92% |
+1,310,367
| New | +$12.1M |
|
8
Alnylam Pharmaceuticals
ALNY
$58.5B
| $11M | 2.65% |
151,553
+72,400
| +91% | +$5.25M |
|
9
Medtronic
MDT
$119B
| $9.4M | 2.27% |
96,464
-35,000
| -27% | -$3.41M |
|
|
ALXN
10
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $9.37M | 2.26% |
71,521
+36,100
| +102% | +$4.73M |
|
|
11
Novartis
NVS
$245B
| $8.3M | 2% |
+90,870
| New | +$8.3M |
|
|
DRNA
12
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $8.29M | 2% |
526,059
-240,921
| -31% | -$3.79M |
|
|
13
Elevance Health
ELV
$71.8B
| $8.28M | 2% |
+29,339
| New | +$8.28M |
|
14
Humana
HUM
$36.5B
| $7.51M | 1.81% |
28,307
+17,490
| +162% | +$4.64M |
|
|
BEAT
15
DELISTED
BioTelemetry, Inc.
BEAT
| $7.41M | 1.79% |
+153,955
| New | +$7.41M |
|
16
UnitedHealth
UNH
$281B
| $7.12M | 1.72% |
29,176
+13,769
| +89% | +$3.36M |
|
17
United Therapeutics
UTHR
$13.8B
| $6.47M | 1.56% |
82,892
+49,237
| +146% | +$3.84M |
|
|
SYNH
18
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $6.43M | 1.55% |
125,899
+44,000
| +54% | +$2.25M |
|
19
Viking Therapeutics
VKTX
$3.04B
| $6.26M | 1.51% |
754,759
-97,401
| -11% | -$808K |
|
|
20
CVS Health
CVS
$92.8B
| $6.2M | 1.49% |
113,738
-253,333
| -69% | -$13.8M |
|
|
RVNC
21
DELISTED
Revance Therapeutics, Inc.
RVNC
| $5.24M | 1.26% |
403,664
+149,083
| +59% | +$1.93M |
|
|
SPPI
22
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $5.2M | 1.25% |
604,019
+50,000
| +9% | +$431K |
|
23
Vertex Pharmaceuticals
VRTX
$100B
| $5.18M | 1.25% |
28,232
| – | – |
|
24
Icon
ICLR
$13.8B
| $4.7M | 1.13% |
30,530
+8,059
| +36% | +$1.24M |
|
25
Integer Holdings
ITGR
$3.78B
| $4.69M | 1.13% |
+55,844
| New | +$4.69M |
|